You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage 5 arteritis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Takayasu Arteritis Trial in Beijing (Tofacitinib 5 MG, Prednisolone, Placebo of tofacitinib 5mg)

Recruiting
  • Takayasu Arteritis
  • Tofacitinib 5 MG
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Feb 19, 2023

Applanation Tonometry in the Diagnosis of Giant Cell Arteritis

Not yet recruiting
  • Giant Cell Arteritis
  • Applanation tonometry
  • Montreal, Quebec, Canada
    Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Jan 26, 2023

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Not yet recruiting
  • Giant Cell Arteritis
  • +2 more
  • Optic nerve ultrasound
  • Joliette, Quebec, Canada
  • +3 more
Feb 18, 2023

Individuals With Takayasu's Arteritis

Completed
  • Takayasu's Arteritis
    • Boston, Massachusetts
    • +8 more
    Jul 11, 2022

    Individuals With Giant Cell Arteritis

    Completed
    • Temporal Arteritis
      • Boston, Massachusetts
      • +8 more
      Jul 11, 2022

      Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)

      Recruiting
      • Takayasu Arteritis
      • Adalimumab Injection
      • Tofacitinib 5 MG
      • Beijing, China
      • +3 more
      Feb 26, 2022

      Giant Cell Arteritis Trial in Worldwide (Guselkumab, Placebo)

      Recruiting
      • Giant Cell Arteritis
      • Kansas City, Kansas
      • +33 more
      Aug 11, 2022

      High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

      Recruiting
      • High-risk Stage II Colorectal Cancer
      • +2 more
      • mFOLFIRINOX adjuvant chemotherapy
      • mFOLFOX6/XELOX adjuvant chemotherapy
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 12, 2023

      Polymyalgia Rheumatica, Effect of Drug, Safety Issues Trial in Shanghai (Tofacitinib 5 MG)

      Completed
      • Polymyalgia Rheumatica
      • +2 more
      • Tofacitinib 5 MG
      • Shanghai, China
        Ren Ji Hospital
      Sep 12, 2022

      Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)

      Active, not recruiting
      • Kidney Diseases
      • +4 more
      • Low PRAL
      • Hillerød, Denmark
        Nordshjaellands Hospital
      Jul 23, 2023

      Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg

      Recruiting
      • Malaria,Falciparum
      • Rabies vaccine
      • +2 more
      • Sigle, Boulkiemdé Province, Burkina Faso
        Institut de Recherche en Sciences de la Santé
      Apr 3, 2023

      Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)

      Recruiting
      • Kidney Diseases
      • +4 more
      • Low PRAL
      • Hillerød, Denmark
        Nordshjaellands Hospital
      Mar 27, 2023

      Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

      Not yet recruiting
      • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
      • +5 more
      • Biospecimen Collection
      • +9 more
      • Scottsdale, Arizona
      • +2 more
      Oct 11, 2023

      Chronic Kidney Diseases, Atrial Fibrillation, Stroke Trial (Apixaban 2.5 milligram Oral Tablet)

      Not yet recruiting
      • Chronic Kidney Diseases
      • +8 more
      • Apixaban 2.5 milligram Oral Tablet
      • (no location specified)
      Jan 8, 2023

      Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

      Recruiting
      • Neoadjuvent
      • +3 more
      • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
      • Xi'an, Shaanxi, China
      • +2 more
      Aug 17, 2023

      Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)

      Not yet recruiting
      • Colorectal Cancer
      • FOLFOX , FOLFIRI or FOLFOXIRI regimens
      • FOLFOX regimen
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Apr 26, 2023

      Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

      Not yet recruiting
      • Advanced Biliary Tract Carcinoma
      • +32 more
      • Biospecimen Collection
      • +6 more
      • Chicago, Illinois
        Northwestern University
      Feb 6, 2023

      Chronic Kidney Disease, Chronic Renal Failure, Chronic Renal Insufficiency Trial in Tainan (ACP board game for life)

      Completed
      • Chronic Kidney Disease
      • +5 more
      • ACP board game for life
      • Tainan, Taiwan
        National Cheng Kung University Hospital
      Sep 21, 2023

      Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)

      Not yet recruiting
      • Primary Hepatocellular Carcinoma
      • Portal Vein Thrombosis
      • Recombinant human adenovirus type 5 + TACE
      • (no location specified)
      May 14, 2023

      CKD Stage 5 Trial in Dallas (EffCaMgCit, CaAcS)

      Active, not recruiting
      • CKD Stage 5
      • Dallas, Texas
        DaVita Dialysis Centers
      Jan 20, 2023

      VCRC Tissue Repository

      Recruiting
      • Aortitis
      • +10 more
        • Boston, Massachusetts
        • +7 more
        Jan 25, 2022

        One-Time DNA Study for Vasculitis

        Recruiting
        • Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
        • +5 more
          • Los Angeles, California
          • +13 more
          May 16, 2022

          Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

          Not yet recruiting
          • Malaria, Plasmodium Falciparum
          • Matrix-M with RH5.2 VLP and/or R21
          • (no location specified)
          Oct 21, 2022

          Efficacy and Safety of Pacitol Inj.

          Recruiting
          • Chronic Kidney Disease 5D
          • Secondary Hyperparathyroidism
            • Goyang-si, Gyeonggi-do, Korea, Republic of
              DongGuk university Ilsan hospital
            Nov 6, 2023

            POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

            Terminated
            • POLE Exonuclease Mutant Colon Cancer
            • +2 more
            • Sutton, Surrey, United Kingdom
              Royal Marsden NHS Foundation Trust
            Oct 5, 2022